American Journal of Cardiovascular Disease Research
ISSN (Print): ISSN Pending ISSN (Online): ISSN Pending Website: https://www.sciepub.com/journal/ajcdr Editor-in-chief: Dario Galante
Open Access
Journal Browser
Go
American Journal of Cardiovascular Disease Research. 2024, 9(1), 7-9
DOI: 10.12691/ajcdr-9-1-2
Open AccessCase Report

Classic Heart Failure Excacerbation with Unexpected Diagnosis of Gallbaldder Adenocarcinoma

Kyrillos Girgis MD1, , Kevin Lipat DO2, Desmond Aroke MD2, Thomas Nubong MD1 and Rafail Beshai DO3

1Department of Internal Medicine, Newark Beth Israel Medical Center, Newark, New Jersey, USA

2Department of Cardiovascular Disease, Newark Beth Israel Medical Center, Newark, New Jersey, USA

3Department of Cardiovascular Disease, Jefferson Health, NJ, Stratford, USA

Pub. Date: February 20, 2024

Cite this paper:
Kyrillos Girgis MD, Kevin Lipat DO, Desmond Aroke MD, Thomas Nubong MD and Rafail Beshai DO. Classic Heart Failure Excacerbation with Unexpected Diagnosis of Gallbaldder Adenocarcinoma. American Journal of Cardiovascular Disease Research. 2024; 9(1):7-9. doi: 10.12691/ajcdr-9-1-2

Abstract

Elevated transaminase and cholestatic enzyme levels are frequently linked to congestive hepatopathy (CH) in the setting of decompensated heart failure. However, other etiologies such hepatitis and acute cholecystitis should still be considered on the differential diagnosis list. Our case describes a very common case of heart failure exacerbation where lab findings may be attributed to CH, however the ultimate diagnosis of gallbladder malignancy was surprising. Our case highlights the importance of performing the workup for elevated liver enzymes in the setting of acute heart failure exacerbation before attributing the cause to CH. Abdominal ultrasound is a cheap and safe tool that should always be considered in cases of elevated transaminases and cholestatic enzymes. It played a pivotal role in the diagnosis of our case.

Keywords:
heart failure congestive hepatopathy unexpected finding gallbladder malignancy abdominal pain

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Møller S., Bernardi M: . Eur Heart J. Sept. 2013, 34: 2804-2811.
 
[2]  Sessa A, Allaire M, Lebray P, Medmoun M, Tiritilli A, Iaria P, Cadranel JF: . JHEP Rep. 2021, 27:100249. .
 
[3]  Fan CQ, Crawford JM (2014: . J Clin Exp Hepatol. 4: 332-346. .
 
[4]  Sherlock S: . Br Heart J. Juill. 1951, 13: 273-293. .
 
[5]  Wells ML, Venkatesh SK: . Abdom Radiol (NY. 2018, 43:.2037-2051. .
 
[6]  Alvarez A.M., Mukherjee D: . Int J Angiol Off Publ Int Coll Angiol Inc. Sept. 2011, 20: 135-142. .
 
[7]  Louie C.Y., Pham M.X., Daugherty T.J., Kambham N., Higgins J.P.T: . Mod Pathol Off J U S Can Acad Pathol Inc. Juill. 2015, 28: 932-943. .
 
[8]  Fidela L.L. Moreno MD, Arthur D. Hagan MD, John R. Holmen MS, T.Allan Pryor PhD, Richard D: . .
 
[9]  Rawla P, Sunkara T, Thandra KC, Barsouk A: . Clin Exp Hepatol. 2019, 5: 93-102. .